The monoclonal antibody XTL 002 [HCV-AB68] has potential in the treatment of chronic hepatitis C virus (HCV) infection

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1578, 2007-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bezafibrate therapy reduces serum hepatitis C virus (HCV) RNA titre in patients with chronic HCV infection

By  

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Potential role for statins in the treatment of chronic HCV infection

By Zhu Qianqian   Han Qunying   Liu Zhengwen  

Future Virology, Vol. 8, Iss. 8, 2013-08 ,pp. : 727-729

Future Medicine

Access to resources Recommend Favorite

PF 03491390 [IDN-6556] appears to lower aminotransferase activity in patients with chronic hepatitis C virus (HCV) infection

By  

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Updated practice guidelines for the treatment of chronic hepatitis C virus (HCV) in Sweden have been developed by a national expert panel.

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 439, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Updated practice guidelines for the treatment of chronic hepatitis C virus (HCV) in Sweden have been developed by a national expert panel.

By  

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite